Switch theme
Sign up to access all valuation multiples
IHH Healthcare Bhd operates a network of healthcare clinics, hospitals, and postoperative rehabilitation centers. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The group’s reportable segments include Hospital and healthcare, Labs, PLife REIT, and Others. A majority of its revenue is generated from the Hospital and healthcare segment, which represents income generated from the provision of healthcare services through its hospitals and healthcare clinics across Singapore, Malaysia, India, Greater China, Turkiye and Europe, and Southeast Asia. Geographically, the group derives maximum revenue from Turkiye and Europe.
2010
70K+
LTM Revenue $5.9B
LTM EBITDA $1.3B
$17.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
IHH Healthcare has a last 12-month revenue (LTM) of $5.9B and a last 12-month EBITDA of $1.3B.
In the most recent fiscal year, IHH Healthcare achieved revenue of $5.8B and an EBITDA of $1.5B.
IHH Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See IHH Healthcare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $5.9B | XXX | $5.8B | XXX | XXX | XXX |
| Gross Profit | $3.8B | XXX | $4.1B | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 72% | XXX | XXX | XXX |
| EBITDA | $1.3B | XXX | $1.5B | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 26% | XXX | XXX | XXX |
| EBIT | $912M | XXX | $920M | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $570M | XXX | $627M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $2.7B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, IHH Healthcare's stock price is MYR 7 (or $2).
IHH Healthcare has current market cap of MYR 60.9B (or $14.4B), and EV of MYR 74.0B (or $17.5B).
See IHH Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17.5B | $14.4B | XXX | XXX | XXX | XXX | $0.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, IHH Healthcare has market cap of $14.4B and EV of $17.5B.
IHH Healthcare's trades at 3.0x EV/Revenue multiple, and 11.8x EV/EBITDA.
Equity research analysts estimate IHH Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
IHH Healthcare has a P/E ratio of 25.2x.
See valuation multiples for IHH Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14.4B | XXX | $14.4B | XXX | XXX | XXX |
| EV (current) | $17.5B | XXX | $17.5B | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | 13.1x | XXX | 11.8x | XXX | XXX | XXX |
| EV/EBIT | 19.2x | XXX | 19.0x | XXX | XXX | XXX |
| EV/Gross Profit | 4.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 25.2x | XXX | 22.9x | XXX | XXX | XXX |
| EV/FCF | 34.0x | XXX | 70.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialIHH Healthcare's last 12 month revenue growth is 8%
IHH Healthcare's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $46K for the same period.
IHH Healthcare's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IHH Healthcare's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for IHH Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | -4% | XXX | XXX | XXX |
| Rule of 40 | 38% | XXX | 34% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $46K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 56% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IHH Healthcare acquired XXX companies to date.
Last acquisition by IHH Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . IHH Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was IHH Healthcare founded? | IHH Healthcare was founded in 2010. |
| Where is IHH Healthcare headquartered? | IHH Healthcare is headquartered in Malaysia. |
| How many employees does IHH Healthcare have? | As of today, IHH Healthcare has 70K+ employees. |
| Is IHH Healthcare publicy listed? | Yes, IHH Healthcare is a public company listed on KLS. |
| What is the stock symbol of IHH Healthcare? | IHH Healthcare trades under 5225 ticker. |
| When did IHH Healthcare go public? | IHH Healthcare went public in 2012. |
| Who are competitors of IHH Healthcare? | Similar companies to IHH Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of IHH Healthcare? | IHH Healthcare's current market cap is $14.4B |
| What is the current revenue of IHH Healthcare? | IHH Healthcare's last 12 months revenue is $5.9B. |
| What is the current revenue growth of IHH Healthcare? | IHH Healthcare revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of IHH Healthcare? | Current revenue multiple of IHH Healthcare is 3.0x. |
| Is IHH Healthcare profitable? | Yes, IHH Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of IHH Healthcare? | IHH Healthcare's last 12 months EBITDA is $1.3B. |
| What is IHH Healthcare's EBITDA margin? | IHH Healthcare's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of IHH Healthcare? | Current EBITDA multiple of IHH Healthcare is 13.1x. |
| What is the current FCF of IHH Healthcare? | IHH Healthcare's last 12 months FCF is $514M. |
| What is IHH Healthcare's FCF margin? | IHH Healthcare's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of IHH Healthcare? | Current FCF multiple of IHH Healthcare is 34.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
